investor1990 previously owned
1430 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by investor1990
DESCRIPTION:

Date updated:05-17-2007

Okay, so I owned all the following stocks back when I thought DNDN was a breakthrough stock that was going to go to 30-40 once the FDA approved it on May 15th. Instead, on May 9th, the FDA issued a complete response letter to Dendreon asking for more information before they could consider approval of Provenge, the company's only drug therapy for late-stage prostate cancer. This took the wind out of the sails of the stock and dropped it down by 60%. I lost more than that percentage of my capital, and sold everything below, mainly at a loss. So if these companies end up going up in the future, I'll be a little upset. However, I learned a valuable lesson about liquidity and time. You can never have enough of either.

symbol name last price % change open
  • +
  • CEGE
    Cell Genesys
  • $0.36
  • 0.00%
  • $N/A

Immunotherapy will be big in coming years for cancer treatment. Competitor to DNDN with prostate cancer therapy, currently in phase 3 testing. Also has phase 2 products for pancreatic cancer and leukemia.

People owning CEGE also tend to own: CAMPELNKFCELIDIXJBLUTALKTIE

TheStreet.com Rating: No Rating What is this?

  • +
  • DNDN
    Dendreon Corporat
  • $27.20
  • -1.23%
  • $27.56

Ground-breaking immunotherapy for prostate cancer. FDA will most likely approve marketing on May 15th. Also has phase 1 trials for breast, ovarian, and colon cancer therapies. This is the next big biotech company and may lead the way to a biotech resurgence in the latter half of the decade.

People owning DNDN also tend to own: GLWUNHACASAHMATBAUYBRLC

TheStreet.com Rating: D- What is this?

  • +
  • NUVO
    N/a
  • $0.30
  • 0.00
  • $0.30

Another biotech focusing on cancer drugs. Partnered with Bayer and Dendreon.

People owning NUVO also tend to own: ABPIACADAGIXAVGNCOLYDEPOMNTA

TheStreet.com Rating: No Rating What is this?

  • +
  • GTW
    Gtw
  • $0.00
  • N/A
  • $N/A

Friendly computer manufacturer. Purchased ahead of upcoming earnings report 4/27/07. Possible short-term trade.

People owning GTW also tend to own: AXPCECOETQFDCINFSSORCTRMM

TheStreet.com Rating: No Rating What is this?

  • +
  • AGEN
    Antigenics Inc.
  • $0.79
  • 0.00%
  • $N/A

Another biotech developing therapudic vaccines for cancer.

People owning AGEN also tend to own: ALXNATHRAVBCATFCXHALJCG

TheStreet.com Rating: D- What is this?

  • +
  • AMD
    Adv Micro Devices
  • $6.95
  • -0.71%
  • $7.01

Top-tier chip manufacturer. Intel has better marketing, but AMD has better technology. Great play if the industry catches on. May start to be tied to Dell, as they use AMD chips.

People owning AMD also tend to own: AAPLCSCODELLGOOGIBMINTCMSFT

TheStreet.com Rating: D- What is this?

  • +
  • BIOM
    N/a
  • $0.54
  • 0.00
  • $0.54

Another cancer biotech focusing on immunotherapy vaccine development.

People owning BIOM also tend to own: ABTABXAAMZNANDWAVBAXCOP

TheStreet.com Rating: No Rating What is this?

  • +
  • DELL
    Dell Inc.
  • $14.32
  • -3.18%
  • $14.59

Underpriced leading computer manufacturer. May see gains as Michael Dell has regained control and turns the company around.

People owning DELL also tend to own: AAPLAMDCSCOGOOGIBMINTCMSFT

TheStreet.com Rating: C+ What is this?

  • Page 1 of 2
  • 1
  • 2
previous next
 

Start Price

Return Value

Start Date
CEGE 4.93 -92.70% Apr 26th
DNDN 16.61 +63.76% Apr 26th
NUVO 4.1416 -92.76% Apr 26th
GTW 2.28 ------ Apr 26th
AGEN 3.47 -77.23% Apr 26th
AMD 14.5715 -52.30% Apr 26th
BIOM 1.24 -56.45% Apr 26th
DELL 24.87 -42.42% Apr 26th
DIS 35.459 -14.75% Apr 26th
INGN 5.16 -93.80% Apr 26th
MOT 17.89 -54.22% Apr 26th
MU 11.90 -36.72% Apr 26th

Average return:

 -45.02%

Success rate:

 9.09%

Deleted Stocks:
MSFT 29.10 +3.26% Apr 26th
SNDK 44.80 +0.78% Apr 26th
LEND 11.1699 ------ Apr 26th
NFI 6.64 ------ Apr 26th

Hated Stocks:
TSCM 10.35 -76.62% Apr 26th

Tracking Started: 04-26-2007

Comments not available

ADD YOUR COMMENTS:

latest articles | popular forums
Black Friday Short-Squeeze Oppor...

By Jonas Elmerraji Posted on Nov. 25, 2009 With Thanksgiving fast approaching, retailers have one thing on their collective minds: Black Friday. After all, the day, whi...

11.25.09 | 13:33 PM
Dividend Stocks for the Week

By Jonas Elmerraji Posted on Nov. 24, 2009 Don’t dismiss dividends right now. While stocks may have made significant strides in the rally that’s taken hold of the m...

11.24.09 | 11:36 AM
This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Nov. 24, 2009 10 Terrific Dividend Stocks: This Barron’s article highlights 10 high-quality dividend-paying stocks for investors who’re ...

11.24.09 | 08:05 AM
Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 23, 2009 As well as broad-based indexes have performed in the last few months, Stockpickr's weekly Rocket Stocks list has managed to d...

11.23.09 | 10:34 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Boycott Mad Money
11.24.09 | 23:14 PM From author Searenity Research
more forums
recent answers | popular answers
bubble(3)
Q. Anyone here planning to trade ar...
11.25.09 | 11:13 AM Asked by Stockpickr Staff #2

A. probably not. a 4 day weekend is
something traders should take advantage
of. ill check the markets, but doubt ill
do anything

show all recent stockpickr answers
today 's lists
52-Week Highs

Here are some of the biggest stocks that made the 52-week high list on Nov. 25, 2009. more

Biggest % Gainers

Here are some of the largest % gainers from Nov. 25, 2009. more

Cramer's Lightning Round

These are the stocks from Jim Cramer's Nov. 24 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more

show all today's lists